SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
X	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* van der Meer Pieter (Last) (First) (Middle) C/O GILDE HEALTHCARE PARTNERS NEWTONLAAN 91 3584 BP (Street) UTRECHT P7 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol BG Medicine, Inc. [ BGMD ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 04/17/2012
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/17/2012		S		200,000	D	$6.6	1,635,432	I	By Gilde Europe Food & Agribusiness Fund B.V.(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* van der Meer Pieter (Last) (First) (Middle) C/O GILDE HEALTHCARE PARTNERS NEWTONLAAN 91 3584 BP (Street) UTRECHT P7 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Gilde Europe Food & Agribusiness Fund B.V. (Last) (First) (Middle) C/O GILDE HEALTHCARE PARTNERS NEWTONLAAN 91 3584 BP (Street) UTRECHT P7 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Gilde Agribusiness Management B.V. (Last) (First) (Middle) C/O GILDE HEALTHCARE PARTNERS NEWTONLAAN 91 3584 BP (Street) UTRECHT P7 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Gilde Healthcare Holding B.V. (Last) (First) (Middle) C/O GILDE HEALTHCARE PARTNERS NEWTONLAAN 91 3584 BP (Street) UTRECHT P7 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* de Graaf Edwin (Last) (First) (Middle) C/O GILDE HEALTHCARE PARTNERS NEWTONLAAN 91 3584 BP (Street) UTRECHT P7 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Perret Marc Olivier (Last) (First) (Middle) C/O GILDE HEALTHCARE PARTNERS NEWTONLAAN 91 3584 BP (Street) UTRECHT P7 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Gilde Europe Food & Agribusiness Partners II C.V. (Last) (First) (Middle) C/O GILDE HEALTHCARE PARTNERS NEWTONLAAN 91 3584 BP (Street) UTRECHT P7 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. The manager of Gilde Europe Food & Agribusiness Fund B.V. is Gilde Agribusiness Management B.V., which is indirectly owned by three managing partners, Pieter van der Meer, Edwin de Graaf and Marc Olivier Perret, through a holding entity, Gilde Healthcare Holding B.V. Gilde Healthcare Holding B.V. is owned in equal thirds by the three managing partners. Gilde Europe Food & Agribusiness Partners II C.V. and Gilde Agribusiness Management B.V. respectively have a 15% and 5% carried interest in Gilde Europe Food & Agribusiness Fund B.V. Pieter van der Meer, Edwin de Graaf and Marc Olivier Perret together have a controlling interest in Gilde Europe Food & Agribusiness Partners II C.V. Each of Pieter van der Meer, Edwin de Graaf, and Marc Olivier Perret disclaim beneficial ownership of the securities except to the extent of his pecuniary interest therein.

	/s/ Pieter van der Meer	04/19/2012
	/s/ Edwin de Graaf	04/19/2012
	/s/ Marc Olivier Perret	04/19/2012
	/s/ Pieter van der Meer, Partner, Gilde Europe Food & Agribusiness Fund B.V.	04/19/2012
	/s/ Pieter van der Meer, Partner, Gilde Agribusiness Management B.V.	04/19/2012
	/s/ Pieter van der Meer, Partner, Gilde Healthcare Holding B.V.	04/19/2012
	/s/ Pieter van der Meer, Partner, Gilde Europe Food & Agribusiness Partners II C.V.	04/19/2012
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.